FDA Approved: ENOXAPARIN SODIUM — Supplemental Application (Amphastar Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approves Amphastar Pharmaceuticals' supplemental application for enoxaparin sodium.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Deep Vein Thrombosis
• Myocardial Infarction
• Pulmonary Embolism

Drugs mentioned

• Enoxaparin sodium (Enoxaparin sodium)

Snippet

SUPPL AP for ENOXAPARIN SODIUM (ENOXAPARIN SODIUM)